Pharma & Bio
Lifestyle
Kang Se-il, CEO of S-Bio CO., LTD.: “New Parkinson’s Drug Demonstrates Competitive Edge in Treating More Severely Affected Patients Compared to U.S. Competitors”
S.Biomedics Co., Ltd.(304360)S.Biomedics Co., Ltd. has released the 24-month follow-up results from the Phase 1/2a clinical trial of its Parkinson’s disease cell therapy “TED-A9” and expressed confide…
KOSDAQ
BIO USA Optimism Boosts BL Pharmtech … D&D Pharmatech Falls on Convertible Bond Conversion [K-Bio Pulse]
South Korea’s pharmaceutical and biotech sector was driven by expectations surrounding BIO USA 2026, the world’s largest global biotech partnering event, on July 23. BL Pharmtech surged on hopes for b…
KOSDAQ
BL Pharmtech Rises on BIO USA Optimism… D&D Pharmatech Inc. Falls on Convertible Bond Conversion [Bio Spotlight]
On the 23rd, the domestic pharmaceutical and biotech sector was driven by market sentiment fueled by anticipation surrounding the global biotech partnering event “BIO USA 2026.” BL Pharmtech posted st…
Lifestyle
[BioUSA] Park Tae-yong, Vice President of Galax: “Conducting Joint Research on AI-Based New Drugs with AstraZeneca on the Premise of Technology Transfer”
Park Tae-yong, Vice President of Galax, is delivering a presentation on the 22nd at the “NOVA Global Connect 2026” event, co-hosted by the Korea Health Industry Development Institute (KHIDI) and Astra…
Technology
Lee Seul-ki, CEO of D&D Pharmatech Inc.: “J.P. Morgan reached out first… We will begin clinical trials for a new antifibrotic drug for liver cirrhosis next year”
D&D Pharmatech Inc.(347850)has entered into full-scale technology transfer negotiations following the release of tissue biopsy results for DD01, a candidate drug for metabolic and alcoholic steatohepa…
Business·Industry
Chip Rally Deepens KOSDAQ Biotech Slump [K-Bio Pulse]
On June 22, South Korea’s benchmark KOSPI market witnessed a symbolic changing of the guard: Samsung Electronics, which had held the No. 1 spot by market capitalization for 24 years, ceded the throne …
Technology
Stock Market Marks 'Nickjeon Day'… Chilly Winds Blow Through KOSDAQ Biotech Market [Bio Spotlight]
On the 22nd, on the Korea Composite Stock Price Index (KOSPI), SamsungElectronics(005930)—which had held the top spot in market capitalization for 24 years—ceded its throne to SK hynix(000660). On tha…
Lifestyle
ECM Skin Boosters Are Popping Up Everywhere—What Are the Two Key Factors to Distinguish the Good from the Bad?
Competition is intensifying as skin boosters based on human tissue-derived extracellular matrix (ECM) are reshaping the market. With the ECM skin booster market expected to continue growing, securing …
Manufacturing
YuyuPharma’s ‘Triple Growth’... Earnings Make a Quantum Leap Thanks to B2C Pet Business in the U.S.
YuyuPharma(000220)has continued its earnings growth trend since the start of this year. Analysts attribute this to improved profitability resulting from streamlined production processes and an optimiz…
Technology
Cg MedTech Hits Daily Price Limit...Hair Loss Stocks Rally on Hopes for Insurance Coverage [K-Bio Pulse]
On June 19, shares of South Korean medical device maker Cg MedTech surged to the daily upper limit on Thursday following reports that its parent company, regenerative medicine specialist CGBio, could …